4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-20-045144
SVP, General Counsel and Sec sold 6,626 shares at an average $20.00 ($132,530)
- SVP, General Counsel and Sec acquired 6,626 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-03 | Option exercise | +6,425 | $7.50 | $48,188 | 23,550 | D |
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-03 | Sale | −6,425 | $20.00 | $128,500 | 17,125 | D |
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-04 | Option exercise | +201 | $7.50 | $1,508 | 17,326 | D |
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-04 | Sale | −201 | $20.05 | $4,030 | 17,125 | D |
| Derivatives | |||||||
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-03 | Option exercise · Stock Option (right to buy) | −6,425 | 143,575 | D | ||
| Sandercock Colin SVP, General Counsel and Sec | 2020-08-04 | Option exercise · Stock Option (right to buy) | −201 | 143,374 | D | ||
| Open-market sales · 6,626 sh · avg $20.00 · $132,530 | |||||||
Loading xslF345X03/doc4.xml…